Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tramadol 100mg effervescent powder sachets sugar free
040702040AAALAL
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | No data available |
|
Tramadol 50mg effervescent powder sachets sugar free
040702040AAAKAK
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | No data available |
|
Tramadol 75mg / Paracetamol 650mg tablets
040702040AABCBC
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | No data available |
|
Tramake 50mg capsules
040702040BCAAAA
|
Tramake | Tramadol hydrochloride | Central Nervous System | No data available |
|
Tramake Insts 100mg sachets
040702040BCACAL
|
Tramake | Tramadol hydrochloride | Central Nervous System | No data available |
|
Tramake Insts 50mg sachets
040702040BCABAK
|
Tramake | Tramadol hydrochloride | Central Nervous System | No data available |
|
Tramazoline 120microg / Dexamethasone 20microg/dose nsl spy
1202010V0AAAAAA
|
Dexamethasone isonicotinate | Dexamethasone isonicotinate | Ear, Nose and Oropharynx | No data available |
|
Trametinib 2mg tablets
0801050CHAAABAB
|
Trametinib | Trametinib | Malignant Disease and Immunosuppression | No data available |
|
Trametinib 500micrograms tablets
0801050CHAAAAAA
|
Trametinib | Trametinib | Malignant Disease and Immunosuppression | No data available |
|
Trandate 100mg/20ml solution for injection ampoules
0204000I0BCAEAA
|
Trandate | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Trandolapril 2mg/5ml oral suspension
0205051U0AAAGAG
|
Trandolapril | Trandolapril | Cardiovascular System | No data available |
|
Tranexamic acid 100mg/5ml oral solution
0211000P0AAAQAQ
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 150mg/5ml oral solution
0211000P0AABFBF
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 1g granules sachets
0211000P0AABGBG
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 1g/5ml oral solution
0211000P0AAAJAJ
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 2.5g/5ml oral solution
0211000P0AAAKAK
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 225mg/5ml oral solution
0211000P0AABABA
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 240mg/5ml oral solution
0211000P0AAAZAZ
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 25mg/5ml oral solution
0211000P0AAAUAU
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 300mg/5ml oral solution
0211000P0AAARAR
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 350mg/5ml oral solution
0211000P0AAAWAW
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 400mg/5ml oral solution
0211000P0AAANAN
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 425mg/5ml oral solution
0211000P0AAAXAX
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Transcath 3 way clear standard silicone catheter male 16Ch-26Ch 30ml balloon
21020000868
|
Transcath 3 way clear standard silicone catheter male 16Ch-26Ch 30ml balloon | Catheters | Appliances | No data available |
|
Transcath 3 way clear standard silicone catheter male 16Ch-26Ch 5-10ml balloon
21020000867
|
Transcath 3 way clear standard silicone catheter male 16Ch-26Ch 5-10ml balloon | Catheters | Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.